Epigenomic Links Between Social Determinants of Health and Symptoms: A Scoping Review. Issue 3 (July 2023)

• Record Type: Journal Article
• Authors: Ray, Mitali; Wallace, McKenzie K.; Grayson, Susan C.; Cummings, Meredith H.; Davis, Jessica A.; Scott, Jewel; Belcher, Sarah M.; Davis, Tara S.; Conley, Yvette P.
• Is Part Of: Biological research for nursing. Volume 25:Issue 3(2023)
• Page Start: 404
• Page End: 416
• Publication Date: 2023-07
• Subjects: social determinants of health -- symptoms -- epigenomic -- epigenetic -- DNA methylation -- health inequities; Clinical biochemistry -- Periodicals; Physiology, Pathological -- Periodicals; Nursing -- Periodicals; Nursing -- Research -- Periodicals; 610.73
• DOI: 10.1177/10998004221147300
• Languages: English
• ISSNs: 1099-8004

Abstract

Social determinants of health (SDoH) impact health and wellness. The link between SDoH and adverse health outcomes, including symptom occurrence and severity, may be explained by an individual's physiologic response to one or more SDoH. One potential mechanism underlying this physiologic response linking SDoH and symptoms is the dynamic epigenome. The purpose of this scoping review of the literature was to examine differential susceptibility for symptoms by identifying and summarizing research linking SDoH and symptoms through epigenomic mechanisms. PubMed was searched to identify empirical research where at least one SDoH was an independent or dependent variable, at least one symptom was investigated, and the investigation included an epigenomic measure. Of the 484 articles initially retrieved, after thorough vetting, 41 articles met eligibility. The most studied symptom was depressive symptoms followed by anxiety, cognitive function, sleep dysfunction, and pain. The most frequently studied SDoH were: 1) stress, particularly early life stress and acculturative stress; and 2) trauma, predominantly childhood trauma. DNA methylation and telomere length were the most studied epigenomic measures. Four genes ( SLC6A4, BDNF, NR3C1, OXTR ) had evidence from multiple studies and across methodological approaches linking SDoH to symptoms. This review supports the inclusion of epigenomic approaches to better understand the link between SDoH and symptoms and provides evidence that SDoH impact telomere length and the methylation of genes involved in neurotransmitter signaling, neuronal survival, behavior, inflammation and stress response.